Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis.
We report a 6-year-old boy with anterior uveitis associated with juvenile idiopathic arthritis (JIA) who underwent cataract extraction in his right eye. One month before surgery he received an intravitreal sustained-release dexamethasone implant. During 10 months' follow-up, his uveitis remained quiet. To our knowledge this is the first report using an intravitreal sustained-release dexamethasone implant as a perioperative anti-inflammatory medication.
Department of Ophthalmology, University Hospital of León, León, Spain; Uveitis Unit, University Hospital of León, León, Spain. Electronic address: miguelcorderocoma@gmail.com.
Miguel
M
Cordero-Coma
Irene
I
Garzo
Sara
S
Calleja
Elena
E
Galán
Manuel
M
Franco
José G
JG
Ruíz de Morales
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001171:Arthritis, Juvenile / Q000150:complications*; D002387:Cataract Extraction; D002648:Child; D002908:Chronic Disease; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D011300:Preoperative Care / Q000379:methods*; D016896:Treatment Outcome; D014606:Uveitis, Anterior / Q000628:therapy*
D000893:Anti-Inflammatory Agents; D004343:Drug Implants; D003907:Dexamethasone